2026-04-14T04:47:31Zhttps://recercat.cat/oai/requestoai:recercat.cat:10230/231872025-12-22T13:40:10Zcom_2072_6col_2072_452952
CMV and Immunosenescence: from basics to clinics
Solana, Rafael
Tarazona, Raquel
Aiello, Allison E.
Akbar, Arne N.
Appay, Victor
Beswick, Mark
Bosch, Jos A.
Campos, Carmen
Cantisán, Sara
Cicin Sain, Luca
Derhovanessian, Evelyna
Ferrando Martínez, Sara
Frasca, Daniela
Fulöp, Tamas
Govind, Sheila
Grubeck Loebenstein, Beatrix
Hill, Ann
Hurme, Mikko
Kern, Florian
Larbi, Anis
López-Botet, M. (Miguel)
Maier, Andrea B.
McElhaney, Janet E.
Moss, Paul
Naumova, Elissaveta
Nikolich Zugich, Janko
Pera, Alejandra
Rector, Jerrarld L.
Riddell, Natalie
Sanchez Correa, Beatriz
Sansoni, Paolo
Sauce, Delphine
Lier, Rene van
Wang, George C.
Wills, Mark R.
Zielinski, Maciej
Pawelec, Graham
Immunitat cel·lular
Alone among herpesviruses, persistent Cytomegalovirus (CMV) markedly alters the numbers and proportions of peripheral immune cells in infected-vs-uninfected people. Because the rate of CMV infection increases with age in most countries, it has been suggested that it drives or at least exacerbates “immunosenescence”. This contention remains controversial and was the primary subject of the Third International Workshop on CMV & Immunosenescence which was held in Cordoba, Spain, 15-16th March, 2012. Discussions focused on several main themes including the effects of CMV on adaptive immunity and immunosenescence, characterization of CMV-specific T cells, impact of CMV infection and ageing on innate immunity, and finally, most important, the clinical implications of immunosenescence and CMV infection. Here we summarize the major findings of this workshop.
The Workshop was partially supported by the University of Cordoba and the Spanish Ministry of Science (SAF2011-16169-E)
2015-03-16T08:16:24Z
2015-03-16T08:16:24Z
2012
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Immunity & Ageing. 2012; 9: 23
info:eu-repo/grantAgreement/ES/3PN/SAF2011-16169
© 2012 Solana et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
http://creativecommons.org/licenses/by/2.0
info:eu-repo/semantics/openAccess
BioMed Central